Investigators report findings from a retrospective study of 13,081 patients undergoing radical cystectomy for bladder cancer.
Latest observation follows reports of new autoimmune phenomena following COVID-19 vaccination, such as IgA nephropathy, rheumatoid arthritis, and systemic lupus erythematosus, investigators noted.
Kidney transplant recipients with bacteremia may be more likely to require outpatient parenteral antibiotics if the infection is caused by bacteria that produce extended-spectrum beta-lactamases.
The rate of AKI requiring dialysis among patients hospitalized with pneumonia was 2.5% for those with CKD compared with 0.03% for those without CKD.
Prophylaxis against Pneumocystis jirovecii pneumonia with trimethoprim-sulfamethoxazole reduced the risk for severe infections by nearly 77%, a study found.
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
New findings provide a rationale for reexamining the hepatitis C virus penalty assigned by the Kidney Donor Profile Index, which is used to indicate the quality of deceased-donor kidneys.
A shift to less invasive management of ureteric stones during the COVID-19 pandemic did not adversely affect the treatment success rate, according to a study conducted in the United Kingdom.
The increased risk for several urinary tract problems among women diagnosed with endometrial cancer varies by age and race or ethnicity, a study found.
In a study, aviremic recipients of HCV-positive and HCV-negative deceased donor kidneys had similar 12-month transplant outcomes.
Inhaled nitric oxide appears to increase the risk for severe acute kidney injury among ICU patients with COVID-19, a French study suggests.
Investigators zero in on mortality risk factors in patients with cancer who contract COVID-19.
Study reveals that almost 90% of men have hypogonadism at the time of hospital admission for COVID-19.
In an address during the American Urological Association’s 2020 Live Virtual Experience, Anthony S. Fauci, MD, a member of the White House Coronavirus Task Force, said the coronavirus pandemic is nowhere near over, but public health measures are making a big difference in reducing the number of cases and related deaths.
Experiences during the COVID-19 crisis could speed changes in healthcare delivery.
